Regulatorische Offenlegungen
Konzernjahresabschluss für 2025
Umsatz
66 870
EUR
'000
30.77
%
EBITDA
5 350
EUR
'000
80.68
%
Marge
Nettogewinn
2 111
EUR
'000
269.66
%
Marge
Regulatorische Offenlegungen
Aktuelle regulatorische Offenlegungen
Änderung der Satzung
16.04.2026
Offenlegung des Aktienrückkaufs durch SIRM
31.03.2026
Offenlegung gemäß Artikel 19 der Verordnung 596
30.03.2026
Disclosure according to Article 19 of Regulation 596
03.03.2026
Archiv
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Q2
2022
Disclosure of purchase of shares by closely related company
12.05.2022
Q2
2022
Disclosure of purchase of shares by closely related company
09.05.2022
Q2
2022
Disclosure of purchase of shares by closely related company
06.04.2022
Q1
2022
Disclosure of purchase of shares by closely related company
31.03.2022
Q1
2022
Disclosure of purchase of shares by closely related company
08.03.2022
Q1
2022
Disclosure of purchase of shares by related company
01.03.2022
Q4
2021
Erwerb einer Mehrheitsbeteiligung an den Aktien von Sciant AD
16.11.2021
Q3
2021
Second publication of quarterly reports
31.08.2021
Q2
2021
Purchase of shares from SGH by related company
07.04.2021
Q1
2021
Opened deposit of daughter company Sirma Solutions
04.02.2021
Q4
2020
Disclosure of opened second deposit by Sirma Solutions with SGH
11.12.2020
Q4
2020
Disclosure of opened deposit by Sirma Solutions with SGH
30.10.2020
Q3
2020
Publication of Protocol from GSM 202001
18.09.2020
Q3
2020
Dividend notification
17.09.2020
Q3
2020
Disclosure of share buy-back by SGH
17.09.2020
Q3
2020
Virtual online participation in the GMS
27.08.2020
Q3
2020
Disclosure of accumulation of considerable share of capital
14.08.2020
Q3
2020
Publication of invitation to GSM202002
13.08.2020
Q3
2020
Invitation to GSM 202001
06.08.2020
Q3
2020
Re-publishing of annual consolidated statements for 2019
03.08.2020
Q3
2020
Change in the date for disclosure of the annual consolidated statements
31.07.2020
Q2
2020
Change in the date for disclosure of the annual consolidated statements
30.06.2020
Q2
2020
Publication of extended periods for disclosure of financial reports
15.04.2020
Q2
2020
Extended periods for disclosure of annual individual reports
02.04.2020
Q1
2020
Disclosure of the impact of COVID 19 on SGH
16.03.2020
No results found
Dropdown
